Drug Shortage Report for INQOVI
Report ID | 152829 |
Drug Identification Number | 02501600 |
Brand name | INQOVI |
Common or Proper name | cedazuridine and decitabine |
Company Name | OTSUKA PHARMACEUTICAL CO LTD |
Market Status | MARKETED |
Active Ingredient(s) | |
Strength(s) | 100MG 35MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | blister |
ATC code | L01BC |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-03-15 |
Actual start date | |
Estimated end date | 2022-05-20 |
Actual end date | 2022-05-20 |
Shortage status | Resolved |
Updated date | 2022-05-27 |
Company comments | Manufacturing delay |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2-9 KANDA-TSUKASAMACHI CHIYODA-KU TOKYO, -- JAPAN 101-8535 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-01-14 | English | Compare |
v2 | 2022-01-14 | English | Compare |
v3 | 2022-01-14 | French | Compare |
v4 | 2022-01-14 | English | Compare |
v5 | 2022-01-14 | French | Compare |
v6 | 2022-01-27 | English | Compare |
v7 | 2022-03-16 | English | Compare |
v8 | 2022-05-09 | English | Compare |
v9 | 2022-05-09 | French | Compare |
v10 | 2022-05-23 | English | Compare |
v11 | 2022-05-23 | French | Compare |
v12 | 2022-05-27 | English | Compare |
Showing 1 to 12 of 12